In looking at their slides I see they have a CF candidate but I think we only invest in potentiators and correctors . Actually I saw on the slides about their Oral delivery of proteins that seems intriguing and I wonder how much potential that could have (longer term).
I do however have a little bit of a hard time investing in them because their business model seems to be to undercut on price .